Number of the records: 1  

Characterization of ferritin 2 for the control of tick infestations

  1. 1.
    SYSNO ASEP0342866
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCharacterization of ferritin 2 for the control of tick infestations
    Author(s) Hajdušek, Ondřej (BC-A) RID, ORCID
    Almazán, C. (MX)
    Loosová, Gabriela (BC-A)
    Villar, M. (ES)
    Canales, M. (ES)
    Grubhoffer, L. (CZ)
    Kopáček, Petr (BC-A) RID, ORCID
    de la Fuente, J. (ES)
    Source TitleVaccine. - : Elsevier - ISSN 0264-410X
    Roč. 28, č. 17 (2010), s. 2993-2998
    Number of pages6 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordstick ferritin 2 ; tick-protective vaccine
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsIAA600960910 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    LC06009 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z60220518 - PAU-O, BC-A (2005-2011)
    UT WOS000276877900011
    DOI10.1016/j.vaccine.2010.02.008
    AnnotationTick iron metabolism pathway was targeted in an effort to identify new tick protective antigens. Recombinant Ixodes ricinus (IrFER2) and Rhipicephalus microplus (RmFER2) ferritin 2 proteins were expressed in Escherichia coli and used to immunize rabbits and cattle, respectively. Vaccination with IrFER2 reduced I. ricinus tick numbers, weight and fertility in rabbits with an overall vaccine efficacy (E) of 98%. Control of cattle tick, R. microplus and Rhipicephalus annulatus infestations was obtained in vaccinated cattle with overall E of 64% and 72%, respectively. Notably, the efficacy of the RmFER2 vaccine was similar to that obtained with Bm86 against R. microplus. These collective results demonstrated the feasibility of using ferritin 2 to develop vaccines for the control of tick infestations.
    WorkplaceBiology Centre (since 2006)
    ContactDana Hypšová, eje@eje.cz, Tel.: 387 775 214
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.